Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
VALUE LINE INC (VALU)
|
Add to portfolio |
|
|
|
| Price: |
$29.05
| | Metrics |
| OS: |
9.43
|
M
| |
22
|
% ROE
|
| Market cap: |
$274
|
M
| |
9
|
% ROIC
|
|
Net cash:
|
$47.5
|
M
| |
$5.04
|
per share
|
|
EV:
|
$226
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$12.8
|
M
| |
17.7
|
x EV/EBITDA
|
|
EBIT
|
$11.5
|
M
| |
19.7
|
x EV/EBIT
|
| EPS |
$1.91
| |
15.2
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Apr-30-23 | Apr-30-22 | Apr-30-21 | Apr-30-20 | Apr-30-19 | Apr-30-18 | Apr-30-17 | Apr-30-16 |
| Revenues | 39.7 | 40.5 | 40.4 | 40.3 | 36.3 | 35.9 | 42.7 | 34.5 |
| Revenue growth | -2.0% | 0.3% | 0.2% | 11.1% | 1.1% | -16.0% | 23.6% | -2.8% |
| Cost of goods sold | 28.2 | 29.7 | 32.9 | 31.2 | 30.8 | 33.3 | -43.4 | 0.0 |
| Gross profit | 11.5 | 10.8 | 7.5 | 9.1 | 5.4 | 2.6 | 86.1 | 34.5 |
| Gross margin | 28.9% | 26.7% | 18.7% | 22.6% | 14.9% | 7.2% | 201.6% | 100.0% |
| Selling, general and administrative | | | | | | | | |
| Sales and marketing | 8.3 | 8.2 | 9.2 | 8.3 | 8.6 | 9.6 | 12.5 | 12.4 |
| General and administrative | 20.0 | 21.5 | 23.7 | 22.9 | 22.2 | 23.7 | 22.7 | 4.6 |
| EBIT | 11.5 | 10.8 | 7.5 | 9.1 | 5.4 | 2.6 | 15.6 | 1.9 |
| EBIT margin | 28.9% | 26.7% | 18.7% | 22.6% | 14.9% | 7.2% | 36.5% | 5.4% |
| Pre-tax income | 23.8 | 30.6 | 30.3 | 20.7 | 16.3 | 11.9 | 15.5 | 10.0 |
| Income taxes | 5.7 | 6.8 | 7.0 | 5.7 | 4.3 | -2.8 | 5.1 | 2.7 |
| Tax rate | 24.0% | 22.2% | 23.1% | 27.6% | 26.4% | | 33.1% | 27.1% |
| Net income | 18.1 | 23.8 | 23.3 | 14.9 | 12.0 | 14.7 | 10.4 | 7.3 |
| Net margin | 45.5% | 58.8% | 57.6% | 37.1% | 33.1% | 41.1% | 24.3% | 21.1% |
| |
| Diluted EPS | $1.91 | $2.50 | $2.43 | $1.55 | $1.24 | $1.52 | $1.07 | $0.75 |
| Shares outstanding (diluted) | 9.5 | 9.5 | 9.6 | 9.6 | 9.7 | 9.7 | 9.7 | 9.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|